Utilizing the Curtis breast cancer data set, we demonstrated that expression of OSM and IL-1β levels in the breast microenvironment are elevated in breast cancer and that high expression of these cytokines leads to increased metastatic potential and reduced breast cancer patient survival. This evidence concerns the gene IL1B and breast cancer.